Arbutus Biopharma Corp Files 8-K on Director/Officer Changes
Ticker: ABUS · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1447028
| Field | Detail |
|---|---|
| Company | Arbutus Biopharma Corp (ABUS) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
Arbutus Biopharma is shuffling its board and officers, filing an 8-K on Feb 24th.
AI Summary
Arbutus Biopharma Corporation filed an 8-K on February 25, 2025, reporting on the departure of a director, the election of new directors, and the appointment of certain officers. The filing also covers compensatory arrangements for officers and other events. The company was formerly known as Tekmira Pharmaceuticals Corp.
Why It Matters
Changes in board composition and officer appointments can signal shifts in company strategy or governance, which are important for investors to monitor.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance changes and does not appear to involve significant financial transactions or operational disruptions.
Key Players & Entities
- Arbutus Biopharma Corporation (company) — Registrant
- Tekmira Pharmaceuticals Corp (company) — Former company name
- February 24, 2025 (date) — Date of earliest event reported
- February 25, 2025 (date) — Date of report
FAQ
What specific items are being reported in this 8-K filing?
This 8-K filing reports on the departure of directors, election of directors, appointment of certain officers, compensatory arrangements of certain officers, and other events.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on February 24, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Arbutus Biopharma Corporation.
What was Arbutus Biopharma Corporation's former name?
Arbutus Biopharma Corporation was formerly known as Tekmira Pharmaceuticals Corp.
What is the company's state of incorporation?
The company's state of incorporation is British Columbia, Canada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding Arbutus Biopharma Corp (ABUS).